Form 4 · Filed Feb 20, 2026, 12:00 PM UTC
ABBV/AbbVie Inc.
Stewart Jeffrey Ryan — EVP, CHIEF COMMERCIAL OFFICER
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | A | other | 26,063 | $0 | — | 79,297 |
| Feb 18, 2026 | A | other | 9,266 | $0 | — | 88,563 |
| Feb 18, 2026 | A | other | 9,432 | $0 | — | 97,995 |
| Feb 18, 2026 | A | other | 8,988 | $0 | — | 106,983 |
| Feb 18, 2026 | A | other | 26,812 | $0 | — | 26,812 |
Source: SEC EDGAR raw filing ↗ · Accession 0001761675-26-000002